VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
reAlpha Tech Corp. vs Novartis AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
reAlpha Tech Corp.
AIRE · Nasdaq Capital Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into reAlpha Tech Corp.'s moat claims, evidence, and risks.
View AIRE analysisNovartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisComparison highlights
- Moat score gap: Novartis AG leads (65 / 100 vs 42 / 100 for reAlpha Tech Corp.).
- Segment focus: reAlpha Tech Corp. has 2 segments (83.5% in Homebuying Platform & Transaction Services); Novartis AG has 5 segments (29.3% in Oncology).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Strong.
- Moat breadth: reAlpha Tech Corp. has 4 moat types across 2 domains; Novartis AG has 4 across 3.
Primary market context
reAlpha Tech Corp.
Homebuying Platform & Transaction Services
Integrated U.S. residential real estate transaction services platform (brokerage + mortgage + title)
United States
Homebuyers
Transaction intermediary / service provider
83.5%
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
reAlpha Tech Corp. strengths
Novartis AG strengths
Segment mix
reAlpha Tech Corp. segments
Full profile >Homebuying Platform & Transaction Services
Competitive
AiChat Conversational AI SaaS
Competitive
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.